US-Listed Biological Products, (No Diagnostic Substances) — Net Income Percentiles, FY 2023
Population: 189 US-listed companies (SIC 2836), fiscal year 2023; fiscal year ends 2023-06-30 to 2024-04-30.
Cite as: FACTANKER, https://factanker.com/industries/sic-2836/net-income/2023
Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest
| 10th percentile | $-254.7M |
|---|---|
| 25th percentile | $-127.0M |
| Median | $-60.4M |
| 75th percentile | $-10.8M |
| 90th percentile | $749.5k |
| Mean | $-38.6M |
| Minimum | $-4.7B |
| Maximum | $6.7B |
Methodology & sources
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2023 = fiscal years ending 2023-06-01 to 2024-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2023 = fiscal years ending 2023-06-01 to 2024-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Evidence samples
Latest Net Income percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries